Sambratha Shetty
Chief Operating Officer, Synergia Foundation
A clear picture of India’s drug discovery
India’s domestic pharmaceutical industry excels in the production of generic medicines but the rate of drug discovery is staggeringly below the global industry average. Drug discovery is an expensive, slow and risky business and most Indian companies do not have sufficient financial resources to take the risk to develop a new drug from scratch. Does India have the resources to become the pharmaceutical powerhouse, it aspires to be?
To read the full research paper, Subscribe.
Krishnan Srinivasan
Former Foreign Secretary, India
The 21st Century Silk Road
PKH Tharakan
Cabinet Secretariat, Govt. of India
Reimagining Intelligence
Jean Louis Bruguiere
Former Judge, EU Anti- Terrorism Court
Tracking Terror Funding in the EU
Pindar Wong
Internet pioneer & Managing Director, VeriFi, Hong Kong
The Cryptocurrency Security Model
HE Shyamal Datta
Former Governor of Nagaland
Two Sides of a Coin: Law Enforcement And internal Security
